HIIFS
ELOS

Harel Insurance Investments & Financial Services’s Syneron Medical Ltd ELOS Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,000
Closed -$34K – 503
2016
Q4 		$34K Hold
4,000
– – ﹤0.01% 219
2016
Q3 		$29K Hold
4,000
– – ﹤0.01% 273
2016
Q2 		$31K Hold
4,000
– – ﹤0.01% 405
2016
Q1 		$29K Hold
4,000
– – ﹤0.01% 250
2015
Q4 		$31K Buy
+4,000
New +$30.5K ﹤0.01% 226

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Harel Insurance Investments & Financial Services's ELOS Position: Q1 2017 in Review

Harel Insurance Investments & Financial Services sold out of Syneron Medical Ltd (ELOS) in Q1 2017, closing a stake of 4,000 shares — an estimated $34K sold.

Harel Insurance Investments & Financial Services first reported a position in ELOS in Q4 2015 and held it in 5 quarters. The position peaked at $34K in Q4 2016. 91 funds tracked by Wall St. Rank hold ELOS as of Q1 2017.

  • Harel Insurance Investments & Financial Services reported no remaining Syneron Medical Ltd position as of Q1 2017 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 4,000 Syneron Medical Ltd shares in Q1 2017, an estimated $34K.
  • Harel Insurance Investments & Financial Services first reported a position in Syneron Medical Ltd in Q4 2015 and held it in 5 quarters.
  • Harel Insurance Investments & Financial Services's Syneron Medical Ltd position peaked at $34K in Q4 2016.
  • 91 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q1 2017.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2017, filed 8 May 2017.